0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharmaceutical Grade Poloxamers Market Research Report 2026
Published Date: 2026-04-08
|
Report Code: QYRE-Auto-33P16869
Home | Market Reports | Business & Industrial| Chemicals Industry| Plastics & Polymers
Global Pharmaceutical Grade Poloxamers Market Research Report 2024
BUY CHAPTERS

Global Pharmaceutical Grade Poloxamers Market Research Report 2026

Code: QYRE-Auto-33P16869
Report
2026-04-08
Pages:111
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pharmaceutical Grade Poloxamers Market

The global Pharmaceutical Grade Poloxamers market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Pharmaceutical Grade Poloxamers competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Poloxamers are nonionic triblock copolymers composed of a central hydrophobic chain of polyoxypropylene (poly(propylene oxide)) flanked by two hydrophilic chains of polyoxyethylene (poly(ethylene oxide)). As well known solubilizers, pharmaceutical grade poloxamers are primarily employed to enhance solubility, absorption, and bioavailability of low-solubility actives. In addition to functioning as solubilizers, poloxamers can also be used as wetting agents, lubricants, or emulsifiers.
The North American market for Pharmaceutical Grade Poloxamers is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Pharmaceutical Grade Poloxamers is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Pharmaceutical Grade Poloxamers include BASF, Croda, Syensqo, Nanjing Well Pharmaceutical, Hubei Hengshuo Chemical, CD Formulation, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Pharmaceutical Grade Poloxamers market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pharmaceutical Grade Poloxamers. The Pharmaceutical Grade Poloxamers market size, estimates, and forecasts are provided in terms of sales volume (Tons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Pharmaceutical Grade Poloxamers market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Pharmaceutical Grade Poloxamers manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Pharmaceutical Grade Poloxamers Market Report

Report Metric Details
Report Name Pharmaceutical Grade Poloxamers Market
Segment by Type
  • Poloxamer 188
  • Poloxamer 124
  • Poloxamer 407
  • Poloxamer 338
  • Others
by Application
  • Injectable Formulation
  • Oral Formulation
  • Topical Formulation
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company BASF, Croda, Syensqo, Nanjing Well Pharmaceutical, Hubei Hengshuo Chemical, CD Formulation
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Pharmaceutical Grade Poloxamers manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Pharmaceutical Grade Poloxamers sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Pharmaceutical Grade Poloxamers Market report?

Ans: The main players in the Pharmaceutical Grade Poloxamers Market are BASF, Croda, Syensqo, Nanjing Well Pharmaceutical, Hubei Hengshuo Chemical, CD Formulation

What are the Application segmentation covered in the Pharmaceutical Grade Poloxamers Market report?

Ans: The Applications covered in the Pharmaceutical Grade Poloxamers Market report are Injectable Formulation, Oral Formulation, Topical Formulation

What are the Type segmentation covered in the Pharmaceutical Grade Poloxamers Market report?

Ans: The Types covered in the Pharmaceutical Grade Poloxamers Market report are Poloxamer 188, Poloxamer 124, Poloxamer 407, Poloxamer 338, Others

1 Pharmaceutical Grade Poloxamers Market Overview
1.1 Product Definition
1.2 Pharmaceutical Grade Poloxamers by Type
1.2.1 Global Pharmaceutical Grade Poloxamers Market Value by Type: 2025 vs 2032
1.2.2 Poloxamer 188
1.2.3 Poloxamer 124
1.2.4 Poloxamer 407
1.2.5 Poloxamer 338
1.2.6 Others
1.3 Pharmaceutical Grade Poloxamers by Application
1.3.1 Global Pharmaceutical Grade Poloxamers Market Value by Application: 2025 vs 2032
1.3.2 Injectable Formulation
1.3.3 Oral Formulation
1.3.4 Topical Formulation
1.4 Global Pharmaceutical Grade Poloxamers Market Size Estimates and Forecasts
1.4.1 Global Pharmaceutical Grade Poloxamers Revenue 2021–2032
1.4.2 Global Pharmaceutical Grade Poloxamers Sales 2021–2032
1.4.3 Global Pharmaceutical Grade Poloxamers Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Pharmaceutical Grade Poloxamers Market Competition by Manufacturers
2.1 Global Pharmaceutical Grade Poloxamers Sales Market Share by Manufacturers (2021–2026)
2.2 Global Pharmaceutical Grade Poloxamers Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Pharmaceutical Grade Poloxamers Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Pharmaceutical Grade Poloxamers, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Pharmaceutical Grade Poloxamers, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Pharmaceutical Grade Poloxamers, Product Types and Applications
2.7 Global Key Manufacturers of Pharmaceutical Grade Poloxamers, Date of Entry into the Industry
2.8 Global Pharmaceutical Grade Poloxamers Market Competitive Situation and Trends
2.8.1 Global Pharmaceutical Grade Poloxamers Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Pharmaceutical Grade Poloxamers Players Market Share by Revenue
2.8.3 Global Pharmaceutical Grade Poloxamers Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pharmaceutical Grade Poloxamers Market Scenario by Region
3.1 Global Pharmaceutical Grade Poloxamers Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Pharmaceutical Grade Poloxamers Sales by Region: 2021–2032
3.2.1 Global Pharmaceutical Grade Poloxamers Sales by Region: 2021–2026
3.2.2 Global Pharmaceutical Grade Poloxamers Sales by Region: 2027–2032
3.3 Global Pharmaceutical Grade Poloxamers Revenue by Region: 2021–2032
3.3.1 Global Pharmaceutical Grade Poloxamers Revenue by Region: 2021–2026
3.3.2 Global Pharmaceutical Grade Poloxamers Revenue by Region: 2027–2032
3.4 North America Pharmaceutical Grade Poloxamers Market Facts & Figures by Country
3.4.1 North America Pharmaceutical Grade Poloxamers Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Pharmaceutical Grade Poloxamers Sales by Country (2021–2032)
3.4.3 North America Pharmaceutical Grade Poloxamers Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pharmaceutical Grade Poloxamers Market Facts & Figures by Country
3.5.1 Europe Pharmaceutical Grade Poloxamers Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Pharmaceutical Grade Poloxamers Sales by Country (2021–2032)
3.5.3 Europe Pharmaceutical Grade Poloxamers Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pharmaceutical Grade Poloxamers Market Facts & Figures by Region
3.6.1 Asia Pacific Pharmaceutical Grade Poloxamers Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Pharmaceutical Grade Poloxamers Sales by Region (2021–2032)
3.6.3 Asia Pacific Pharmaceutical Grade Poloxamers Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pharmaceutical Grade Poloxamers Market Facts & Figures by Country
3.7.1 Latin America Pharmaceutical Grade Poloxamers Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Pharmaceutical Grade Poloxamers Sales by Country (2021–2032)
3.7.3 Latin America Pharmaceutical Grade Poloxamers Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Pharmaceutical Grade Poloxamers Market Facts & Figures by Country
3.8.1 Middle East and Africa Pharmaceutical Grade Poloxamers Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Pharmaceutical Grade Poloxamers Sales by Country (2021–2032)
3.8.3 Middle East and Africa Pharmaceutical Grade Poloxamers Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pharmaceutical Grade Poloxamers Sales by Type (2021–2032)
4.1.1 Global Pharmaceutical Grade Poloxamers Sales by Type (2021–2026)
4.1.2 Global Pharmaceutical Grade Poloxamers Sales by Type (2027–2032)
4.1.3 Global Pharmaceutical Grade Poloxamers Sales Market Share by Type (2021–2032)
4.2 Global Pharmaceutical Grade Poloxamers Revenue by Type (2021–2032)
4.2.1 Global Pharmaceutical Grade Poloxamers Revenue by Type (2021–2026)
4.2.2 Global Pharmaceutical Grade Poloxamers Revenue by Type (2027–2032)
4.2.3 Global Pharmaceutical Grade Poloxamers Revenue Market Share by Type (2021–2032)
4.3 Global Pharmaceutical Grade Poloxamers Price by Type (2021–2032)
5 Segment by Application
5.1 Global Pharmaceutical Grade Poloxamers Sales by Application (2021–2032)
5.1.1 Global Pharmaceutical Grade Poloxamers Sales by Application (2021–2026)
5.1.2 Global Pharmaceutical Grade Poloxamers Sales by Application (2027–2032)
5.1.3 Global Pharmaceutical Grade Poloxamers Sales Market Share by Application (2021–2032)
5.2 Global Pharmaceutical Grade Poloxamers Revenue by Application (2021–2032)
5.2.1 Global Pharmaceutical Grade Poloxamers Revenue by Application (2021–2026)
5.2.2 Global Pharmaceutical Grade Poloxamers Revenue by Application (2027–2032)
5.2.3 Global Pharmaceutical Grade Poloxamers Revenue Market Share by Application (2021–2032)
5.3 Global Pharmaceutical Grade Poloxamers Price by Application (2021–2032)
6 Key Companies Profiled
6.1 BASF
6.1.1 BASF Company Information
6.1.2 BASF Description and Business Overview
6.1.3 BASF Pharmaceutical Grade Poloxamers Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 BASF Pharmaceutical Grade Poloxamers Product Portfolio
6.1.5 BASF Recent Developments/Updates
6.2 Croda
6.2.1 Croda Company Information
6.2.2 Croda Description and Business Overview
6.2.3 Croda Pharmaceutical Grade Poloxamers Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Croda Pharmaceutical Grade Poloxamers Product Portfolio
6.2.5 Croda Recent Developments/Updates
6.3 Syensqo
6.3.1 Syensqo Company Information
6.3.2 Syensqo Description and Business Overview
6.3.3 Syensqo Pharmaceutical Grade Poloxamers Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Syensqo Pharmaceutical Grade Poloxamers Product Portfolio
6.3.5 Syensqo Recent Developments/Updates
6.4 Nanjing Well Pharmaceutical
6.4.1 Nanjing Well Pharmaceutical Company Information
6.4.2 Nanjing Well Pharmaceutical Description and Business Overview
6.4.3 Nanjing Well Pharmaceutical Pharmaceutical Grade Poloxamers Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Nanjing Well Pharmaceutical Pharmaceutical Grade Poloxamers Product Portfolio
6.4.5 Nanjing Well Pharmaceutical Recent Developments/Updates
6.5 Hubei Hengshuo Chemical
6.5.1 Hubei Hengshuo Chemical Company Information
6.5.2 Hubei Hengshuo Chemical Description and Business Overview
6.5.3 Hubei Hengshuo Chemical Pharmaceutical Grade Poloxamers Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Hubei Hengshuo Chemical Pharmaceutical Grade Poloxamers Product Portfolio
6.5.5 Hubei Hengshuo Chemical Recent Developments/Updates
6.6 CD Formulation
6.6.1 CD Formulation Company Information
6.6.2 CD Formulation Description and Business Overview
6.6.3 CD Formulation Pharmaceutical Grade Poloxamers Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 CD Formulation Pharmaceutical Grade Poloxamers Product Portfolio
6.6.5 CD Formulation Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pharmaceutical Grade Poloxamers Industry Chain Analysis
7.2 Pharmaceutical Grade Poloxamers Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pharmaceutical Grade Poloxamers Production Mode & Process Analysis
7.4 Pharmaceutical Grade Poloxamers Sales and Marketing
7.4.1 Pharmaceutical Grade Poloxamers Sales Channels
7.4.2 Pharmaceutical Grade Poloxamers Distributors
7.5 Pharmaceutical Grade Poloxamers Customer Analysis
8 Pharmaceutical Grade Poloxamers Market Dynamics
8.1 Pharmaceutical Grade Poloxamers Industry Trends
8.2 Pharmaceutical Grade Poloxamers Market Drivers
8.3 Pharmaceutical Grade Poloxamers Market Challenges
8.4 Pharmaceutical Grade Poloxamers Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Pharmaceutical Grade Poloxamers Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Pharmaceutical Grade Poloxamers Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Pharmaceutical Grade Poloxamers Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Pharmaceutical Grade Poloxamers Sales (Tons) of Key Manufacturers (2021–2026)
 Table 5. Global Pharmaceutical Grade Poloxamers Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Pharmaceutical Grade Poloxamers Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Pharmaceutical Grade Poloxamers Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Pharmaceutical Grade Poloxamers Average Price (US$/Ton) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Pharmaceutical Grade Poloxamers, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Pharmaceutical Grade Poloxamers, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Pharmaceutical Grade Poloxamers, Product Types and Applications
 Table 12. Global Key Manufacturers of Pharmaceutical Grade Poloxamers, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Pharmaceutical Grade Poloxamers Companies by Tier (Tier 1, Tier 2, Tier 3), based on Pharmaceutical Grade Poloxamers Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Pharmaceutical Grade Poloxamers Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Pharmaceutical Grade Poloxamers Sales by Region (Tons), 2021–2026
 Table 18. Global Pharmaceutical Grade Poloxamers Sales Market Share by Region (2021–2026)
 Table 19. Global Pharmaceutical Grade Poloxamers Sales by Region (Tons), 2027–2032
 Table 20. Global Pharmaceutical Grade Poloxamers Sales Market Share by Region (2027–2032)
 Table 21. Global Pharmaceutical Grade Poloxamers Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Pharmaceutical Grade Poloxamers Revenue Market Share by Region (2021–2026)
 Table 23. Global Pharmaceutical Grade Poloxamers Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Pharmaceutical Grade Poloxamers Revenue Market Share by Region (2027–2032)
 Table 25. North America Pharmaceutical Grade Poloxamers Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Pharmaceutical Grade Poloxamers Sales by Country (Tons), 2021–2026
 Table 27. North America Pharmaceutical Grade Poloxamers Sales by Country (Tons), 2027–2032
 Table 28. North America Pharmaceutical Grade Poloxamers Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Pharmaceutical Grade Poloxamers Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Pharmaceutical Grade Poloxamers Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Pharmaceutical Grade Poloxamers Sales by Country (Tons), 2021–2026
 Table 32. Europe Pharmaceutical Grade Poloxamers Sales by Country (Tons), 2027–2032
 Table 33. Europe Pharmaceutical Grade Poloxamers Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Pharmaceutical Grade Poloxamers Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Pharmaceutical Grade Poloxamers Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Pharmaceutical Grade Poloxamers Sales by Region (Tons), 2021–2026
 Table 37. Asia Pacific Pharmaceutical Grade Poloxamers Sales by Region (Tons), 2027–2032
 Table 38. Asia Pacific Pharmaceutical Grade Poloxamers Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Pharmaceutical Grade Poloxamers Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Pharmaceutical Grade Poloxamers Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Pharmaceutical Grade Poloxamers Sales by Country (Tons), 2021–2026
 Table 42. Latin America Pharmaceutical Grade Poloxamers Sales by Country (Tons), 2027–2032
 Table 43. Latin America Pharmaceutical Grade Poloxamers Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Pharmaceutical Grade Poloxamers Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Pharmaceutical Grade Poloxamers Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Pharmaceutical Grade Poloxamers Sales by Country (Tons), 2021–2026
 Table 47. Middle East and Africa Pharmaceutical Grade Poloxamers Sales by Country (Tons), 2027–2032
 Table 48. Middle East and Africa Pharmaceutical Grade Poloxamers Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Pharmaceutical Grade Poloxamers Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Pharmaceutical Grade Poloxamers Sales (Tons) by Type (2021–2026)
 Table 51. Global Pharmaceutical Grade Poloxamers Sales (Tons) by Type (2027–2032)
 Table 52. Global Pharmaceutical Grade Poloxamers Sales Market Share by Type (2021–2026)
 Table 53. Global Pharmaceutical Grade Poloxamers Sales Market Share by Type (2027–2032)
 Table 54. Global Pharmaceutical Grade Poloxamers Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Pharmaceutical Grade Poloxamers Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Pharmaceutical Grade Poloxamers Revenue Market Share by Type (2021–2026)
 Table 57. Global Pharmaceutical Grade Poloxamers Revenue Market Share by Type (2027–2032)
 Table 58. Global Pharmaceutical Grade Poloxamers Price (US$/Ton) by Type (2021–2026)
 Table 59. Global Pharmaceutical Grade Poloxamers Price (US$/Ton) by Type (2027–2032)
 Table 60. Global Pharmaceutical Grade Poloxamers Sales (Tons) by Application (2021–2026)
 Table 61. Global Pharmaceutical Grade Poloxamers Sales (Tons) by Application (2027–2032)
 Table 62. Global Pharmaceutical Grade Poloxamers Sales Market Share by Application (2021–2026)
 Table 63. Global Pharmaceutical Grade Poloxamers Sales Market Share by Application (2027–2032)
 Table 64. Global Pharmaceutical Grade Poloxamers Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Pharmaceutical Grade Poloxamers Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Pharmaceutical Grade Poloxamers Revenue Market Share by Application (2021–2026)
 Table 67. Global Pharmaceutical Grade Poloxamers Revenue Market Share by Application (2027–2032)
 Table 68. Global Pharmaceutical Grade Poloxamers Price (US$/Ton) by Application (2021–2026)
 Table 69. Global Pharmaceutical Grade Poloxamers Price (US$/Ton) by Application (2027–2032)
 Table 70. BASF Company Information
 Table 71. BASF Description and Business Overview
 Table 72. BASF Pharmaceutical Grade Poloxamers Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 73. BASF Pharmaceutical Grade Poloxamers Product
 Table 74. BASF Recent Developments/Updates
 Table 75. Croda Company Information
 Table 76. Croda Description and Business Overview
 Table 77. Croda Pharmaceutical Grade Poloxamers Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 78. Croda Pharmaceutical Grade Poloxamers Product
 Table 79. Croda Recent Developments/Updates
 Table 80. Syensqo Company Information
 Table 81. Syensqo Description and Business Overview
 Table 82. Syensqo Pharmaceutical Grade Poloxamers Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 83. Syensqo Pharmaceutical Grade Poloxamers Product
 Table 84. Syensqo Recent Developments/Updates
 Table 85. Nanjing Well Pharmaceutical Company Information
 Table 86. Nanjing Well Pharmaceutical Description and Business Overview
 Table 87. Nanjing Well Pharmaceutical Pharmaceutical Grade Poloxamers Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 88. Nanjing Well Pharmaceutical Pharmaceutical Grade Poloxamers Product
 Table 89. Nanjing Well Pharmaceutical Recent Developments/Updates
 Table 90. Hubei Hengshuo Chemical Company Information
 Table 91. Hubei Hengshuo Chemical Description and Business Overview
 Table 92. Hubei Hengshuo Chemical Pharmaceutical Grade Poloxamers Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 93. Hubei Hengshuo Chemical Pharmaceutical Grade Poloxamers Product
 Table 94. Hubei Hengshuo Chemical Recent Developments/Updates
 Table 95. CD Formulation Company Information
 Table 96. CD Formulation Description and Business Overview
 Table 97. CD Formulation Pharmaceutical Grade Poloxamers Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 98. CD Formulation Pharmaceutical Grade Poloxamers Product
 Table 99. CD Formulation Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. Pharmaceutical Grade Poloxamers Distributors List
 Table 103. Pharmaceutical Grade Poloxamers Customers List
 Table 104. Pharmaceutical Grade Poloxamers Market Trends
 Table 105. Pharmaceutical Grade Poloxamers Market Drivers
 Table 106. Pharmaceutical Grade Poloxamers Market Challenges
 Table 107. Pharmaceutical Grade Poloxamers Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Pharmaceutical Grade Poloxamers
 Figure 2. Global Pharmaceutical Grade Poloxamers Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Pharmaceutical Grade Poloxamers Market Share by Type: 2025 & 2032
 Figure 4. Poloxamer 188 Product Picture
 Figure 5. Poloxamer 124 Product Picture
 Figure 6. Poloxamer 407 Product Picture
 Figure 7. Poloxamer 338 Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Pharmaceutical Grade Poloxamers Market Value by Application (US$ Million), 2021–2032
 Figure 10. Global Pharmaceutical Grade Poloxamers Market Share by Application: 2025 & 2032
 Figure 11. Injectable Formulation
 Figure 12. Oral Formulation
 Figure 13. Topical Formulation
 Figure 14. Global Pharmaceutical Grade Poloxamers Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 15. Global Pharmaceutical Grade Poloxamers Market Size (US$ Million), 2021–2032
 Figure 16. Global Pharmaceutical Grade Poloxamers Sales (Tons), 2021–2032
 Figure 17. Global Pharmaceutical Grade Poloxamers Average Price (US$/Ton), 2021–2032
 Figure 18. Pharmaceutical Grade Poloxamers Report Years Considered
 Figure 19. Pharmaceutical Grade Poloxamers Sales Share by Manufacturers in 2025
 Figure 20. Global Pharmaceutical Grade Poloxamers Revenue Share by Manufacturers in 2025
 Figure 21. Top 5 and Top 10 Global Pharmaceutical Grade Poloxamers Players: Market Share by Revenue in Pharmaceutical Grade Poloxamers in 2025
 Figure 22. Pharmaceutical Grade Poloxamers Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 23. Global Pharmaceutical Grade Poloxamers Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 24. North America Pharmaceutical Grade Poloxamers Sales Market Share by Country (2021–2032)
 Figure 25. North America Pharmaceutical Grade Poloxamers Revenue Market Share by Country (2021–2032)
 Figure 26. United States Pharmaceutical Grade Poloxamers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. Canada Pharmaceutical Grade Poloxamers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. Europe Pharmaceutical Grade Poloxamers Sales Market Share by Country (2021–2032)
 Figure 29. Europe Pharmaceutical Grade Poloxamers Revenue Market Share by Country (2021–2032)
 Figure 30. Germany Pharmaceutical Grade Poloxamers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. France Pharmaceutical Grade Poloxamers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. U.K. Pharmaceutical Grade Poloxamers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Italy Pharmaceutical Grade Poloxamers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Russia Pharmaceutical Grade Poloxamers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Asia Pacific Pharmaceutical Grade Poloxamers Sales Market Share by Region (2021–2032)
 Figure 36. Asia Pacific Pharmaceutical Grade Poloxamers Revenue Market Share by Region (2021–2032)
 Figure 37. China Pharmaceutical Grade Poloxamers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Japan Pharmaceutical Grade Poloxamers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. South Korea Pharmaceutical Grade Poloxamers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. India Pharmaceutical Grade Poloxamers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Australia Pharmaceutical Grade Poloxamers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. China Taiwan Pharmaceutical Grade Poloxamers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Southeast Asia Pharmaceutical Grade Poloxamers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Latin America Pharmaceutical Grade Poloxamers Sales Market Share by Country (2021–2032)
 Figure 45. Latin America Pharmaceutical Grade Poloxamers Revenue Market Share by Country (2021–2032)
 Figure 46. Mexico Pharmaceutical Grade Poloxamers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Brazil Pharmaceutical Grade Poloxamers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Argentina Pharmaceutical Grade Poloxamers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Colombia Pharmaceutical Grade Poloxamers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Middle East and Africa Pharmaceutical Grade Poloxamers Sales Market Share by Country (2021–2032)
 Figure 51. Middle East and Africa Pharmaceutical Grade Poloxamers Revenue Market Share by Country (2021–2032)
 Figure 52. Turkey Pharmaceutical Grade Poloxamers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Saudi Arabia Pharmaceutical Grade Poloxamers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. UAE Pharmaceutical Grade Poloxamers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. Global Sales Market Share of Pharmaceutical Grade Poloxamers by Type (2021–2032)
 Figure 56. Global Revenue Market Share of Pharmaceutical Grade Poloxamers by Type (2021–2032)
 Figure 57. Global Pharmaceutical Grade Poloxamers Price (US$/Ton) by Type (2021–2032)
 Figure 58. Global Sales Market Share of Pharmaceutical Grade Poloxamers by Application (2021–2032)
 Figure 59. Global Revenue Market Share of Pharmaceutical Grade Poloxamers by Application (2021–2032)
 Figure 60. Global Pharmaceutical Grade Poloxamers Price (US$/Ton) by Application (2021–2032)
 Figure 61. Pharmaceutical Grade Poloxamers Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS